PRIMMUNE THERAPEUTICS, INC.
CARLSBAD, CALIFORNIA 920081691
$10.63M
Total Contract Value
13 awards
First Award
Jan 30, 2024
Last Award
Jul 25, 2025
Business Size
small
CAGE Code
8J8L4
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $10.63M | 11 |
Contract Awards
5 awards found
HDTRA124C0014
Department of Defense
$1.39M
May 20, 2025
ORAL BROAD SPECTRUM ANTIVIRAL TLR7
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
HDTRA124C0014
Department of Defense
$1.39M
Nov 19, 2024
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER.
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
HDTRA124C0014
Department of Defense
$5.22M
May 22, 2024
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
HDTRA124C0014
Department of Defense
$1.78M
Apr 17, 2024
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
HDTRA124C0014
Department of Defense
$846K
Jan 30, 2024
ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
Business Details
- UEI
- RCE3KW671H83
- CAGE Code
- 8J8L4
- Address
- 2333 STATE STREET, SUITE 203
CARLSBAD, CA 920081691 - Congressional District
- CA-49
- Phone
- 8582052281
Parent Company
PRIMMUNE THERAPEUTICS, INC.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov